Publications of Roland Ullrich

Rueger, M. A.; Backes, H.; Walberer, M.; Neumaier, B.; Ullrich, R.; Simard, M.-L.; Emig, B.; Fink, G. R.; Hoehn, M.; Graf, R. et al.; Schroeter, M.: Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. Journal of Neuroscience 30 (18), pp. 6454 - 6460 (2010)

Weiss, J.; Sos, M. L.; Seidel, D.; Peifer, M.; Zander, T.; Heuckmann, J. M.; Ullrich, R. T.; Menon, R.; Maier, S.; Soltermann, A. et al.; Moch, H.; Wagener, P.; Fischer, F.; Heynck, S.; Koker, M.; Schöttle, J.; Leenders, F.; Gabler, F.; Dabow, I.; Querings, S.; Heukamp, L. C.; Balke-Want, H.; Ansén, S.; Rauh, D.; Baessmann, I.; Altmüller, J.; Wainer, Z.; Conron, M.; Wright, G.; Russell, P.; Solomon, B.; Brambilla, E.; Brambilla, C.; Lorimier, P.; Sollberg, S.; Brustugun, O. T.; Engel-Riedel, W.; Ludwig, C.; Petersen, I.; Sänger, J.; Clement, J.; Groen, H.; Timens, W.; Sietsma, H.; Thunnissen, E.; Smit, E.; Heidemann, D.; Cappuzzo, F.; Ligorio, C.; Damiani, S.; Hallek, M.; Beroukhim, R.; Pao, W.; Klebl, B.; Baumann, M.; Buettner, R.; Ernestus, K.; Stoelben, E.; Wolf, J.; Nürnberg, P.; Perner, S.; Thomas, R. K.: Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Science Translational Medicine 2 (62), p. 62ra93 - 62ra93 (2010)

Ullrich, R.; Kracht, L.; Brunn, A.; Herholz, K.; Frommolt, P.; Miletic, H.; Deckert, M.; Heiss, W.-D.; Jacobs, A. H.: Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine 50 (12), pp. 1962 - 1968 (2009)

Kobus, D.; Giesen, Y.; Ullrich, R.; Backes, H.; Neumaier, B.: A fully automated two-step synthesis of an 18F-labelled tyrosine kinase inhibitor for EGFR kinase activity imaging in tumors. Applied Radiation and Isotopes 67 (11), pp. 1977 - 1984 (2009)

Sos, M. L.; Fischer, S.; Ullrich, R.; Peifer, M.; Heuckmann, J. M.; Koker, M.; Heynck, S.; Stueckrath, I.; Weiss, J.; Fischer, F. et al.; Michel, K.; Goel, A.; Regales, L.; Politi, K. A.; Perera, S.; Getlik, M.; Heukamp, L. C.; Ansen, S.; Zander, T.; Beroukhim, R.; Kashkar, H.; Shokat, K. M.; Sellers, W. R.; Rauh, D.; Orr, C.; Hoeflich, K. P.; Friedman, L.; Wong, K.-K.; Pao, W.; Thomas, R. K.: Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. Proceedings of the National Academy of Sciences of the United States of America 106, pp. 18351 - 18356 (2009)

Galldiks, N.; Ullrich, R.; Schroeter, M.; Fink, G. R.; Kracht, L. W.: Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen. Journal of Neuro-Oncology 93 (3), pp. 425 - 430 (2009)

Sos, M. L.; Michel, K.; Zander, T.; Weiss, J.; Frommolt, P.; Peifer, M.; Li, D.; Ullrich, R.; Koker, M.; Fischer, F. et al.; Shimamura, T.; Rauh, D.; Mermel, C.; Fischer, S.; Stückrath, I.; Heynck, S.; Beroukhim, R.; Lin, W.; Winckler, W.; Shah, K.; LaFramboise, T.; Moriarty, W. F.; Hanna, M.; Tolosi, L.; Rahnenführer, J.; Verhaak, R.; Chiang, D.; Getz, G.; Hellmich, M.; Wolf, J.; Girard, L.; Peyton, M.; Weir, B. A.; Chen, T.-H.; Greulich, H.; Barretina, J.; Shapiro, G. I.; Garraway, L. A.; Gazdar, A. F.; Minna, J. D.; Meyerson, M.; Wong, K.-K.; Thomas, R. K.: Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. Journal of Clinical Investigation 119 (6), pp. 1727 - 1740 (2009)

Backes, H.; Ullrich, R.; Neumaier, B.; Kracht, L.; Wienhard, K.; Jacobs, A. H.: Non-invasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high grade glioma. European Journal of Nuclear Medicine and Molecular Imaging 36 (12), pp. 1960 - 1967 (2009)

Ullrich, R. T.; Zander, T.; Neumaier, B.; Koker, M.; Shimamura, T.; Waerzeggers, Y.; Borgman, C. L.; Tawadros, S.; Li, H.; Sos, M. L. et al.; Backes, H.; Shapiro, G. I.; Wolf, J.; Jacobs, A. H.; Thomas, R. K.; Winkeler, A.: Early detection of erlotinib treatment response in NSCLC by 3'-Deoxy-3'-[18F]-fluoro-L-thymidine ([18F]FLT) positron emission tomography (PET). PLoS ONE 3 (12), p. e3908 - e3908 (2008)

Lehnhardt, F.-G.; Horvath, R.; Ullrich, R.; Kracht, L.; Sobesky, J.; Möller-Hartmann, W.; Jacobs, A. H.; Haupt, W. F.: Altered cerebral glucose metabolism in a family with clinical features resembling mitochondrial neurogastrointestinal encephalomyopathy syndrome in association with multiple mitochondrial DNA deletions. Archives of Neurology 65 (3), pp. 407 - 411 (2008)

Ullrich, R.; Backes, H.; Li, H.; Kracht, L.; Miletic, H.; Kesper, K.; Neumaier, B.; Heiss, W.-D.; Wienhard, K.; Jacobs, A. H.: Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clinical Cancer Research 14 (7), pp. 2049 - 2055 (2008)

Ullrich, R. T.; Kracht, L. W.; Jacobs, A. H.: Neuroimaging in patients with gliomas. Seminars in Neurology 28 (4), pp. 484 - 494 (2008)

Waerzeggers, Y.; Monfared, P.; Ullrich, R.; Viel, T.: Multimodality imaging: Overview of imaging techniques (CT, MRI, PET, optical imaging) and impact of multimodality imaging on drug development. In: Trends on the role of PET in drug development, pp. 319 - 382 (Eds. Elsinga, P. H.; Van Waarde, A.; Paans, A.M.J.; Dierckx, R.A.J.O.). World Scientific Publ. (2012)